The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease

This publication has 135 references indexed in Scilit:

• Endotoxin-binding Proteins Modulate the Susceptibility of Bacterial Endotoxin to Deacylation by Acyloxyacyl Hydrolase
  Published by Elsevier ,2007
• Expression and Antimicrobial Function of Bactericidal Permeability-Increasing Protein in Cystic Fibrosis Patients
  Infection and Immunity, 2006
• Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria
  Nature Immunology, 2005
• BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing ofE. coliDH5α in vitro
  Pediatric Pulmonology, 2004
• Bactericidal/Permeability-Increasing Protein Is Expressed by Human Dermal Fibroblasts and Upregulated by Interleukin 4
  Clinical and Vaccine Immunology, 2003
• Points of control in inflammation
  Nature, 2002
• Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis
  QJM: An International Journal of Medicine, 1996
• THE RECOMBINANT 23-kDa N-TERMINAL FRAGMENT OF BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN (rBPI23) DECREASES ESCHERICHIA COLI-INDUCED MORTALITY AND ORGAN INJURY DURING IMMUNOSUPPRESSION-RELATED NEUTROPENIA
  Shock, 1995
• Structural characterization of BPI-modulating 15 kDa proteins from rabbit polymorphonuclear leukocytes: Identification of a novel family of leukocyte proteins
  Inflammation Research, 1993
• Relation between binding and the action of phospholipases A2 on Escherichia coli exposed to the bactericidal/permeability-increasing protein of neutrophils
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987